HIGHLIGHTS
- who: Tianrong Yeo from the Department of Pharmacology, University of Oxford, Mansfield Road, Oxford , QT, UK have published the paper: Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model, in the Journal: (JOURNAL)
- what: Using this approach in MS patients, the authors have shown that beyond diagnostic purposes , metabolomics can offer useful information on clinical activity by distinguishing relapse from remission at both group and individual levels , and predicting the clinical conversion of clinically isolated syndrome to MS .
SUMMARY
At least 90 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.